Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowden, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowden, K
American Journal of Health-System Pharmacy, Vol 58, Issue suppl_1, S14-S16
Copyright © 2001 by American Society of Health-System Pharmacists


Articles

Managing up to maximize medicare reimbursement for outpatient care

K Bowden


An example of managing up through participation in a multidisciplinary team tasked with maximizing reimbursement under the Medicare ambulatory patient classification (APC) system is described. Medicare's new system of payment for hospital outpatient services replaces the cost-based reimbursement model of the past with a technical payment based on the outpatient evaluation and management level. Individual institutions are responsible for developing criteria for defining technical visit levels. Managers at the New England Medical Center formed a team to develop these criteria. The team outlined components of the patient visit that qualified as technical costs, such as the use of space at a facility, medical and surgical supplies, and nonphysician professional services. Team members then contacted each of the center's clinics to identify specific services that met these criteria. After formulating the technical visit level criteria, the team determined who would assign the technical visit level, wrote policies and procedures, and trained staff. The APC team also assessed billing procedures, focusing particularly on the accuracy of the charge master and the use of proper codes and billing units for pass-through drugs. The team continues to monitor its results by reviewing payments received from Medicare and auditing high-risk areas. The APC team used the principles of managing up to maximize Medicare reimbursement for outpatient visits.
 



This article has been cited by other articles:


Home page
CirculationHome page
S. R. Mehta, P. G. Steg, C. B. Granger, J.-P. Bassand, D. P. Faxon, J. I. Weitz, R. Afzal, B. Rush, R. J.G. Peters, M. K. Natarajan, et al.
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial
Circulation, March 22, 2005; 111(11): 1390 - 1397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.